👁️ Trip Together: Why Psychedelics Work Better in Groups

Wellness doesn’t have to be boring! Drop the ordinary with Oasis Drops, the highest quality, consistent, and versatile magical mushroom tincture on the market. Perfect for everyday use, a night out, or looking within. A new era in mental health has arrived.

Use code OASIS20 for 20% off your first order!

Did you know that microdosing and macrodosing psychedelics serve different purposes and lead to very different experiences?

Microdosing involves taking a small amount of psychedelics—usually around 1/10 to 1/20 of a full dose. This subtle approach can lead to changes in mood, creativity, and productivity without inducing hallucinations or visual effects. Many find that microdosing uplifts their mood and perspectives while allowing them to go about their day, and it has been shown to positively impact mental health.

On the other hand, macrodosing means taking a larger amount to achieve an intense and potentially transformative experience. This can result in altered states of consciousness, hallucinations, and even "ego death." Macrodosing has been associated with profound experiences that help treat mental health conditions like depression, anxiety, and addiction.

Ultimately, the choice between microdosing and macrodosing depends on individual goals and the desired outcome of the psychedelic experience.

Gotta Blast 🚀:

• The social cure: New research suggests group settings can amplify the healing power of psychedelics, fostering deeper connections and empathy.

• Federal focus: Agencies see promise in psychedelic therapy for PTSD but emphasize the need for more research to ensure safety and effectiveness.

• Trip-free treatment: Psilera's psilocybin drug aims to treat dementia without the psychedelic effects, offering a new approach to therapy.

Quote of the Week 📖:

CHANGING MINDS🧠

Psychedelics and the Power of Community 🧠

New research from Nature Mental Health suggests that the key to unlocking the full potential of psychedelics might lie in the power of community. While psychedelics like LSD and psilocybin have shown promise in treating conditions such as depression, anxiety, and PTSD, the typical clinical approach often misses a crucial element: the social context.

Traditionally, many cultures have used psychedelics in group ceremonies, where the shared experience and collective support play a pivotal role in the journey.

The study highlights that group settings can amplify the therapeutic benefits of psychedelics by fostering a sense of connection and belonging.

This "social cure" model proposes that the presence of others who are on a similar path can make the experience more profound. It’s not just about feeling less alone—being in a group can help individuals process difficult emotions, gain new perspectives, and build lasting bonds. These social dynamics can lead to a deeper integration of the psychedelic experience, promoting empathy, self-awareness, and a sense of unity.

However, implementing group-based psychedelic therapy isn’t without its challenges. Legal restrictions, safety concerns, and the complexity of group dynamics are all factors that need careful consideration. Yet, the study argues that, with responsible facilitation and a structured approach, group settings could pave the way for more effective and holistic treatments.

In a world where many feel isolated in their struggles, community-focused psychedelic therapy might just be the missing piece, offering a more connected path to mental well-being.

More in the Space 👁️

👁️ LSD and amphetamines alter brain connectivity in unique ways.

MOVING THE NEEDLE🪡

Federal Agencies Signal Hope for Psychedelic Therapy 🌿

In a recent meeting, federal officials from agencies like the Department of Defense, HHS, and the VA discussed the future of PTSD treatments, with psychedelic-assisted therapy taking a prominent role. While MDMA and similar substances have shown promise in alleviating symptoms, the consensus was clear: more research is essential to confirm their safety and efficacy.

Hosted by the Reagan-Udall Foundation for the FDA, the session highlighted a growing interest in psychedelics as viable treatments, even if they’re not yet ready for mainstream use (in the FDA’s eyes).

Betty Aldworth of MAPS noted that psychedelics dominated the conversation. "Nearly every speaker discussed their potential in a meeting that wasn’t specifically about psychedelics,” she said, reflecting the public's increasing interest in these therapies. This discussion follows the FDA's recent decision not to approve MDMA-assisted therapy for PTSD, a move Aldworth described as "heartbreaking" for those who view psychedelics as their last hope for effective treatment.

Meanwhile, the VA is already taking steps forward, recently opening funding requests for research into MDMA- and psilocybin-assisted therapies. Acting Director Miriam J. Smyth revealed that veterans may soon have more opportunities to participate in these groundbreaking trials. The stakes are high, but early results are promising. "This first randomized clinical trial at VA seems to have produced stunning and robust results," said Rachel Yehuda, director of mental health at the VA's James J. Peters Veterans Affairs Medical Center. While FDA approval is still a hurdle, the momentum behind psychedelic therapy is undeniable.

As Michael Mithoefer put it, "If these treatments can get approved, it would be a huge leap forward." For now, the focus is on expanding research to gather the data needed to make this vision a reality.

👁️ Psilera's psilocybin drug offers hope for dementia—minus the trip.

News for humans, by humans.

• Today's news.

• Edited to be unbiased as humanly possible.

• Every morning, we triple-check headlines, stories, and sources for bias.

• All by hand with no algorithms.

Sign up now!

COMMUNITY PULSE 🌐

_{PSYCHEDELIC MEME}

psychspacemedia

View more on Instagram

_{LET’S LEARN}

Psychedelics Are Here to Stay 🌱

Dennis Walker, aka Mycopreneur, is reshaping the psychedelic space with humor and insight. As the host of the Mycopreneur Podcast, Walker dives into the intersection of psychedelics, entrepreneurship, and the growing fungi industry. He emphasizes the importance of community, satire, and open-source sharing in the psychedelic world. With projects like a Microdosing Facilitator Training program and Mycoday mushroom products in the works, Walker is all about making psychedelics accessible to everyone!

Want to know how he's changing the game?

Psychedelic Panic: The Truth Behind the Shruumz Recall 🍫

The Diamond Shruumz chocolate recall has sparked panic, with 113 reported illnesses across 28 states. While some media outlets have rushed to blame psychedelics like psilocin and 4-AcO-DMT, the actual culprit remains a mystery. As the story unfolds, many are concerned that fear-mongering could overshadow the true issues in the unregulated market. Inaccurate reporting threatens to derail the progress of psychedelic legalization and microdosing practices.

Curious about what's really happening?

_{PODCASTS/VIDEOS/BOOKS:}

The Nature of Ayahuasca Documentary

Theo Von’s Comedy on Mushrooms

_{EVENTS/COURSES/RETREATS:}

The Psychedelic Professionals Networking Club

📅Dates: September 26th @ 4pm PST / 7pm EST

Online

Welcome to The Psychedelic Professionals Networking Club! A bi-monthly virtual gathering, bringing together like-minded individuals who have committed their work and businesses to psychedelic medicine. Join to connect, exchange ideas, share insights, and much more with other professionals in this unique and growing field.

Psilocybin Conference 2024

📅Dates: November 9-10, 2024

Online

We’re thrilled to invite you to the Psilocybin Conference 2024, a two-day event where leading experts will dive deep into the latest research, therapeutic applications, and legal aspects of psilocybin. Featuring speakers from Zendo, DanceSafe, Chacruna and other renowned organizations, this conference will equip you with the knowledge and insights needed to understand the legality of psilocybin mushrooms and how they can be used to fit your unique needs.

BEFORE WE GO😢

Thank you for reading and being a part of this psychedelic journey! 🍄

👁️ Are you a psychedelic therapist/coach, retreat center, or brand looking to elevate your content? PSYCHSPACE Creations is here to help. Book a consultation call with us today and let’s bring your vision to life!

👁️ Have a question or want to build a partnership? Message us! [email protected]